Liraglutide-13C5,15N (tetraTFA) is a version of Liraglutide labeled with 13C and 15N isotopes. Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, which is clinically used for the treatment of type 2 diabetes.
Target:
Glucagon Receptor
* VAT and and shipping costs not included. Errors and price changes excepted
